Exhibit 107
Calculation of Filing Fee Tables
Form 424(b)(5)
(Form Type)
Cytokinetics, Incorporated
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Offering Price |
Fee Rate |
Amount of Registration Fee(2) |
Carry Forward Form Type |
Carry Forward File Number |
Carry Forward Initial Effective Date |
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||||||||||||||
| Fees to Be Paid |
Equity | Common Stock, par value $0.0001 per share | 457 | (r) | 11,274,510 | $ | 51.00 | $ | 575,000,010 | 0.00014760 | $ | 84,870.01 | — | — | — | — | ||||||||||||||||||||
| Fees Previously Paid |
— | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||||||||||||||
| Carry Forward Securities |
— | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||
| Total Offering Amounts |
|
$ | 575,000,010 | $ | 84,870.01 | |||||||||||||||||||||||||||||||
| Total Fees Previously Paid |
|
— | — | |||||||||||||||||||||||||||||||||
| Total Fee Offsets |
|
— | — | |||||||||||||||||||||||||||||||||
| Net Fee Due |
|
$ | 84,870.01 | |||||||||||||||||||||||||||||||||
| (1) | Includes 1,470,588 shares of common stock the underwriters have an option to purchase. |
| (2) | Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the “Securities Act”). The fee payable in connection with the offering pursuant to this prospectus supplement has been paid in accordance with Rule 456(b) under the Securities Act and represents deferred payment of the registration fees in connection with the Registrant’s Registration Statement on Form S-3 (Registration No. 333-268483) (the “Registration Statement”). |